Anesthesiology · 1987 · 243 citations · 0 references
PharmacyPharmacokineticsPharmacologyPediatric Clinical PharmacologyPediatric PharmacotherapyPediatric TherapeuticsAge-related Pharmacokinetic DifferencesAge-related PharmacokineticsDrug Half-lifeNeonatal PharmacologyPediatric PharmacokineticsPediatric PharmacologyAge-dependent ClearanceAge-dependent PharmacokineticsChild PharmacokineticsDrug Elimination Half-lifeDrug Half-life In ChildrenPharmacokinetics In InfancyPharmacokinetics In Neonates
The pharmacokinetics of morphine in ten infants less than or equal to 10 weeks of age who were receiving morphine infusions were determined. Infants 1-4 days of age (newborns) showed longer elimination half-lives than the older infants (6.8 vs. 3.9 h). Clearance in the newborns is less than one-half that found in older infants (6.3 vs. 23.8 ml X min-1 X kg-1). The combination of lower clearance and longer elimination half-life in newborns (0-7 days) may well explain a prolonged duration of action for morphine in very young infants, but other etiologies are needed to explain the respiratory sensitivity believed to persist in older infants.